Spectacle Magnification and Aniseikonia
Spectacle Magnification and Aniseikonia
SM = shape factor × power factor. A +8.00 D lens at 12 mm magnifies 13.65%, a +5.00 D one 9.30%, and the 4.35% difference between them is the aniseikonia anisometropia produces.
Two lens powers → image size difference
Shape and power factors+8.00 D and +5.00 D at a 12 mm vertex distance, both lenses with a +10.00 D front surface, 4 mm thick, n = 1.50 — the published worked case
Spectacle magnification, and the difference between two eyes
- the power factor
- 1 ÷ (1 − dFᵥ), with the vertex distance in metres. It is the SAME denominator as vertex compensation, where the power needed at the cornea is F ÷ (1 − dF) — so the power factor is exactly the ratio of the compensated power to the prescribed one. A lens that needs vertex compensation is a lens that magnifies, by the same proportion
- the shape factor
- 1 ÷ (1 − (t⁄n)F₁), which depends on the front surface and the thickness and not on the lens’s power at all. It is also, term for term, the thickness factor in the back vertex power of a thick lens: one expression, two jobs
- WHY A PERCENT-PER-DIOPTRE RULE CANNOT BE RIGHT
- no source read for this batch states one, and the arithmetic shows why none can: at a 12 mm vertex distance the power factor gives 1.215% per dioptre at +1.00 D, 1.261% at +4.00 D and 1.364% at +10.00 D, it is smaller in minus than in plus, and all of it scales with the vertex distance. The per-dioptre figure above is computed, not quoted
- the strata, quoted and attributed
- the course notes read give, verbatim: “>0.75% is clinically significant and can produce symptoms”; “1-3% aniseikonia is thought to produce definit [sic] symptoms and binocular fusion difficulties”; “3-5% may be clinically significant”; and “>5% aniseikonia is not compatible with binocular vision”. THOSE STATEMENTS DISAGREE about where clinical significance starts, all four are printed in the table below rather than one being chosen, and no second source was read for them
Worked example
+8.00 D and +5.00 D at a 12 mm vertex distance, both lenses with a +10.00 D front surface, 4 mm thick, n = 1.50 — the published worked case
Reduced thickness. 4 ÷ 1.50 = 2.667 mm, or 0.002667 m
Shape factor. 1 ÷ (1 − 0.002667 × 10.00) = 1 ÷ 0.973333 = 1.0274, which is the “about 1.027” the source prints
Power factor, first eye. 1 ÷ (1 − 0.012 × 8.00) = 1 ÷ 0.904 = 1.1062, the source's “about 1.106”, or 10.6% on its own
Spectacle magnification. 1.0274 × 1.1062 = 1.1365, so %M = 13.65 — the source's “roughly 14 per cent”
Fellow eye. 1 ÷ (1 − 0.012 × 5.00) = 1.0638; × 1.0274 = 1.0930, so %M = 9.30
Aniseikonia. 13.65 − 9.30 = 4.35% of image size difference, from 3.00 D of anisometropia
Move the lenses out. At a 16 mm vertex distance the same two powers give 18.0% and 11.9%, a difference of 6.11% — so 4 mm of vertex distance is worth nearly two per cent of aniseikonia. At zero vertex distance the difference is 0.00%, because the power factor is 1 for both eyes
Where it refuses. Set the first eye to +50.00 D and the vertex distance to 20 mm and no answer appears: 1 − dFᵥ is exactly zero and the magnification is unbounded
Power factor magnification at three vertex distances
| Back vertex power | %M at 10 mm | %M at 12 mm | %M at 14 mm | Per dioptre at 12 mm |
|---|---|---|---|---|
| +1.00 D | 1.01 | 1.21 | 1.42 | 1.215 |
| +2.00 D | 2.04 | 2.46 | 2.88 | 1.230 |
| +4.00 D | 4.17 | 5.04 | 5.93 | 1.261 |
| +6.00 D | 6.38 | 7.76 | 9.17 | 1.293 |
| +8.00 D | 8.70 | 10.62 | 12.61 | 1.327 |
| +10.00 D | 11.11 | 13.64 | 16.28 | 1.364 |
| −4.00 D | −3.85 | −4.58 | −5.31 | 1.146 |
| −8.00 D | −7.41 | −8.76 | −10.07 | 1.095 |
The published aniseikonia statements, as one source gives them
| Image size difference | What the source says | Printed here as |
|---|---|---|
| Over 0.75% | “is clinically significant and can produce symptoms” | The first band boundary |
| 1% to 3% | “thought to produce definit [sic] symptoms and binocular fusion difficulties” | The second band |
| 3% to 5% | “may be clinically significant (>0.75% image size difference)” | The third band, and a contradiction of the first row |
| Over 5% | “is not compatible with binocular vision” | The fourth band |
| Any value | Nothing about what to do about it | Nothing — this page recommends no action |
A spectacle lens changes the size of the retinal image, and two unequal lenses change it unequally
A spectacle lens does not only refocus the image, it resizes it. The published decomposition, which all three sources read print identically, splits the effect in two. The POWER factor, 1 ÷ (1 − dFᵥ), depends on the lens’s power and how far it sits from the eye; the SHAPE factor, 1 ÷ (1 − (t⁄n)F₁), depends on the front surface and the thickness and not on the power at all. Their product is the spectacle magnification, and one less than it, times a hundred, is the percentage a dispenser talks in.
The power factor is worth recognising, because it is vertex distance compensation seen from the other side: the power a lens needs at the cornea is F ÷ (1 − dF), so the magnification is exactly the ratio of the compensated power to the prescribed one. A lens strong enough to need vertex compensation magnifies by the same proportion. The shape factor is likewise the thickness term from thick lens back vertex power, doing the same arithmetic on a different quantity.
Where it earns its keep is the difference between two eyes. Anisometropia means two unequal powers, two unequal magnifications and two retinal images of different sizes — aniseikonia. At 12 mm a +8.00 D and a +5.00 D lens of the same form give 13.65% and 9.30%, a difference of 4.35% from 3.00 D of anisometropia. Move them to 16 mm and it becomes 6.11%; put them on the cornea and it becomes zero, because the power factor is 1 at a vertex distance of zero and the shared shape factor cancels. That last line is the arithmetic behind a familiar clinical observation, and the observation is not this page’s to make.
Two things this page refuses to do. It does not quote a percentage of aniseikonia per dioptre of anisometropia, because no source read states one and the quantity is not constant: at 12 mm it runs from 1.215% per dioptre at 1.00 D to 1.364% at 10.00 D, it is smaller in minus than in plus, and it scales with the vertex distance. And it does not reconcile the published strata, which say both that 0.75% is clinically significant and that 3% to 5% “may be”. A computed estimate is also not a measurement: aniseikonia is measured directly, the retinal and cortical contribution is in none of this arithmetic, and an axial anisometropia is expected to behave differently from a refractive one. For the prescription this starts from, see the spherical equivalent and transposition.
Frequently asked questions
How do I calculate spectacle magnification?
Multiply the shape factor, 1 ÷ (1 − (t⁄n)F1), by the power factor, 1 ÷ (1 − dFv), then subtract one and multiply by a hundred for a percentage. A +8.00 D lens at 12 mm with a +10.00 D front surface 4 mm thick at n = 1.50 gives 1.0274 × 1.1062 = 1.1365, or 13.65%.
How much aniseikonia does anisometropia cause?
The difference between the two lenses’ magnifications. At 12 mm, +8.00 D and +5.00 D of the same form give 13.65% and 9.30%, so 4.35% from 3.00 D of anisometropia. It is not a fixed percentage per dioptre: the real figure runs from 1.215% at 1.00 D to 1.364% at 10.00 D and scales with the vertex distance.
Why does a contact lens produce less aniseikonia than spectacles?
Because the power factor is 1 ÷ (1 − dFv), and at a vertex distance of zero that is exactly 1 whatever the power. With the power factor gone and a common shape factor the computed difference falls to zero. What follows clinically is a judgement this page does not make.
What is the difference between the shape and power factors?
The power factor depends on the back vertex power and the vertex distance; the shape factor depends on the front surface, the thickness and the index, and not on the power. That is why lens FORM is a lever over image size.
How much aniseikonia is too much?
The one source read says four things and two of them disagree: over 0.75% “is clinically significant and can produce symptoms”, 1-3% is “thought to produce definit [sic] symptoms”, 3-5% “may be clinically significant”, and over 5% “is not compatible with binocular vision”. All four are printed here, unreconciled, and what any of it means for a particular patient is a clinical question.
Related calculators
References
- Optician’s Friend. Optics Study Guide. opticiansfriend.com. Accessed 10 October 2026. (The page states that its information may contain mistakes and should be independently verified, so every formula taken from it here is corroborated from a second source.)
- Open Exam Prep. Section 3.2: Lens Thickness, Magnification and Effective Power, ABO Advanced study guide. open-exam-prep.com. Accessed 10 October 2026.
- Aniseikonia, Binocular Vision Anomalies course notes hosted at umsl.edu/~garziar. University of Missouri-St. Louis. Accessed 10 October 2026.
- Musladin MG. Reduced Thickness. 20/20 Magazine continuing education, 2020mag.com, October 2023. (Works the back vertex power of a +9.40 / −4.70 lens, 5.2 mm thick, n = 1.586, step by step as plain text to +5.00 D; every step was recomputed here and the result reproduced exactly.)
Not medical advice. For healthcare professionals and education. Reference intervals vary by laboratory and assay — always use your own laboratory's. Never base a dose or a treatment decision on this page alone. Full disclaimer at calcengines.com/disclaimer/